Miao Huang

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Does neoadjuvant chemoimmune therapy confer benefits to all NSCLC patients?

Does neoadjuvant chemoimmune therapy confer benefits to all NSCLC patients?

Journal: Future oncology (London, England)

Published: October 03, 2025

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma.

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma.

Journal: Molecular cancer

Published: February 22, 2025

Establishing a threshold for maximum standardized uptake value on 18 F-fluorodeoxyglucose PET/CT to predict high-grade lung adenocarcinoma and its prognostic significance.

Establishing a threshold for maximum standardized uptake value on 18 F-fluorodeoxyglucose PET/CT to predict high-grade lung adenocarcinoma and its prognostic significance.

Journal: Nuclear medicine communications

Published: February 12, 2025

The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial.

The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial.

Journal: BMC medicine

Published: October 27, 2024

Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection.

Genome-Scale Multimodal Analysis of Cell-Free DNA Whole-Methylome Sequencing for Noninvasive Esophageal Cancer Detection.

Journal: JCO precision oncology

Published: July 08, 2024

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center.

Beneficial implications of adjuvant chemotherapy for stage IB lung adenocarcinoma exhibiting elevated SUVmax in FDG-PET/CT: a retrospective study from a single center.

Journal: Frontiers in oncology

Published: January 08, 2024

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments.

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments.

Journal: Nature communications

Published: November 10, 2022

Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer.

Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer.

Journal: International journal of general medicine

Published: July 29, 2021

Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review

Occlusion with Bronchial Covered Stent in the Management of Bronchial Stump Fistula after Right Middle and Lower Lobectomy: A Case Report and Literature Review

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: April 29, 2021

Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer

Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer

Published: April 05, 2021

Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.

Clinical recommendations for perioperative immunotherapy-induced adverse events in patients with non-small cell lung cancer.

Journal: Thoracic cancer

Published: March 01, 2021

High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.

High-risk-pattern lung adenocarcinoma with epidermal growth factor receptor mutation is associated with distant metastasis risk and may benefit from adjuvant targeted therapy.

Journal: Interactive cardiovascular and thoracic surgery

Published: November 17, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026